1. Epidemiology of clinical benign prostatic hyperplasia;Lim;Asian J Urol,2017
2. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates;Eqan;Urol Clin North Am,2016
3. Perioperative and periprocedural management of antithrombotic therapy: consensus document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU;Vivas;Rev Esp Cardiol (Engl Ed),2018
4. Gravas S, Cornu JN, Drake MJ, et al. EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) 2018 edition. European Association of Urology; 2019.
5. The morbidity associated with a TURP procedure in routine clinical practice, as graded by the modified Clavien-Dindo system;Saqen;Scand J Urol,2019